Product limit estimation for infectious disease data when the diagnostic test for the outcome is measured with uncertainty.

Low sensitivity and/or specificity of a diagnostic test for outcome results in biased estimates of the time to first event using product limit estimation. For example, if a test has low specificity, estimates of the cumulative distribution function (cdf) are biased towards time zero, while estimates of the cdf are biased away from time zero if a test has low sensitivity. In the context of discrete time survival analysis for infectious disease data, we develop self-consistent algorithms to obtain unbiased estimates of the time to first event when the sensitivity and/or specificity of the diagnostic test for the outcome is less than 100%. Two examples are presented. The first involves estimating time to first detection of HIV-1 infection in infants in a randomized clinical trial, and the second involves estimating time to first Neisseria gonorrhoeae infection in a cohort of Kenyan prostitutes.

[1]  G. V. van Doornum,et al.  Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by ligase chain reaction-based assays with clinical specimens from various sites: implications for diagnostic testing and screening , 1996, Journal of clinical microbiology.

[2]  Xiao-Li Meng,et al.  Using EM to Obtain Asymptotic Variance-Covariance Matrices: The SEM Algorithm , 1991 .

[3]  F. Onyango,et al.  Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. , 2000, JAMA.

[4]  D. Rubin,et al.  Maximum likelihood from incomplete data via the EM - algorithm plus discussions on the paper , 1977 .

[5]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data , 1980 .

[6]  B. Richardson,et al.  Estimation of the Joint Distribution of Infection Timeand Death Time for Vertical Transmission of HIV-1 , 1999 .

[7]  K. Carroll,et al.  Evaluation of the Abbott LCx Ligase Chain Reaction Assay for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine and Genital Swab Specimens from a Sexually Transmitted Disease Clinic Population , 1998, Journal of Clinical Microbiology.

[8]  B. Richardson,et al.  Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. , 1998, The Journal of infectious diseases.

[9]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[10]  L. Magder,et al.  Logistic regression when the outcome is measured with uncertainty. , 1997, American journal of epidemiology.

[11]  E. Karita,et al.  An assessment of the timing of mother-to-child transmission of human immunodeficiency virus type 1 by means of polymerase chain reaction. , 1994, Journal of acquired immune deficiency syndromes.

[12]  S. George,et al.  Planning the size and duration of a clinical trial studying the time to some critical event. , 1974, Journal of chronic diseases.